Ki67 is a better marker than PRAME in risk stratification of BAP1-positive and BAP1-loss uveal melanomas.
Piotr DonizyMikołaj SpytekMateusz KrzyzińskiKrzysztof KotowskiAnna MarkiewiczBozena Romanowska-DixonPrzemyslaw BiecekMai P HoangPublished in: The British journal of ophthalmology (2023)
A panel of Ki67 and BAP1 could be a helpful risk stratification strategy for UM.